98 Serial response in patients with small cell carcinoma of the lung (SCCL) treated with chemotherapy
β Scribed by Rushing, D.A.; Friedenberg, W.R.; Tipping, S.J.; Broste, S.; Rodvold, K.A.
- Book ID
- 122815960
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 149 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The records of 65 consecutive patients with non-small-cell lung cancer (NSCLC) treated with intensive induction chemotherapy were reviewed to study the infectious complications during therapy and to analyze the relationship of the frequency of infections to various predisposing factors. A total of 4
Twenty-four evaluable patients with small cell carcinoma of the lung were treated with an escalating chemotherapy regimen including Cyclophosphamide, Adriamycin, Vincristine and VP16-213. The initial doses were CTX 800 mg/m2 i.v. day 1; ADR 50 mg/m2 i.v. day 1; VCR 1.4 mg/m2 day 1 weekly; and VP16-2